Anatomic & Clinical Pathology in Vero Beach, FL
9 verified anatomic & clinical pathology doctors in Vero Beach.
Pathologists diagnose disease by examining tissue, blood, and other lab specimens.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Dr. Richard Whisnant, MD
Anatomic & Clinical Pathology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Ramesh Ramanathan, MD
Anatomic & Clinical Pathology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Ira Gleiberman, MD
Anatomic & Clinical Pathology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Julie Bell, MD
Anatomic & Clinical Pathology
CMS Open Payments· $261.92 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$261.92
Total received
3
Transactions
3
Paying companies
Top paying companies
Among the 16,988 anatomic & clinical pathology doctors we've analyzed, about 17% received any industry payment (median $71 among those who did). This doctor's total is higher than 97% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US anatomic & clinical pathology doctors.
Payments to Julie Bell do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Neil Medalie, MD
Anatomic & Clinical Pathology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Dian Feng, MD
Anatomic & Clinical Pathology
CMS Open Payments· $13.98 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$13.98
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 16,988 anatomic & clinical pathology doctors we've analyzed, about 17% received any industry payment (median $71 among those who did). This doctor's total ranks around the 84th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US anatomic & clinical pathology doctors.
Payments to Dian Feng do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Neal Mccollum, MD
Anatomic & Clinical Pathology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Mary Varsegi, MD
Anatomic & Clinical Pathology
CMS Open Payments· $14.04 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$14.04
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 16,988 anatomic & clinical pathology doctors we've analyzed, about 17% received any industry payment (median $71 among those who did). This doctor's total ranks around the 84th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US anatomic & clinical pathology doctors.
Payments to Mary Varsegi do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Andrea Jones, MD
Anatomic & Clinical Pathology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.